Publication date: Mar 24, 2025
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a leading global health challenge, especially in low-resource settings. Accurate diagnosis from chest X-rays is critical yet challenging due to subtle manifestations of TB, particularly in its early stages. Traditional computational methods, primarily using basic convolutional neural networks (CNNs), often require extensive pre-processing and struggle with generalizability across diverse clinical environments. This study introduces a novel Vision Transformer (ViT) model augmented with Gradient-weighted Class Activation Mapping (Grad-CAM) to enhance both diagnostic accuracy and interpretability. The ViT model utilizes self-attention mechanisms to extract long-range dependencies and complex patterns directly from the raw pixel information, whereas Grad-CAM offers visual explanations of model decisions about highlighting significant regions in the X-rays. The model contains a Conv2D stem for initial feature extraction, followed by many transformer encoder blocks, thereby significantly boosting its ability to learn discriminative features without any pre-processing. Performance testing on a validation set had an accuracy of 0. 97, recall of 0. 99, and F1-score of 0. 98 for TB patients. On the test set, the model has accuracy of 0. 98, recall of 0. 97, and F1-score of 0. 98, which is better than existing methods. The addition of Grad-CAM visuals not only improves the transparency of the model but also assists radiologists in assessing and verifying AI-driven diagnoses. These results demonstrate the model’s higher diagnostic precision and potential for clinical application in real-world settings, providing a massive improvement in the automated detection of TB.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | tuberculosis |
pathway | KEGG | Tuberculosis |
drug | DRUGBANK | Flunarizine |
drug | DRUGBANK | Tropicamide |
pathway | REACTOME | Reproduction |
disease | MESH | COVID 19 |
disease | MESH | infections |
disease | MESH | tic |
disease | IDO | quality |
disease | IDO | process |
disease | IDO | history |
disease | MESH | tuberculous meningitis |
disease | MESH | privacy |
drug | DRUGBANK | Nonoxynol-9 |
disease | MESH | aids |
disease | MESH | pulmonary diseases |
pathway | REACTOME | Translation |
drug | DRUGBANK | Coenzyme M |
drug | DRUGBANK | Esomeprazole |
drug | DRUGBANK | Polyethylene glycol |
drug | DRUGBANK | Vildagliptin |
disease | MESH | anomalies |
disease | IDO | algorithm |
drug | DRUGBANK | Saquinavir |
disease | MESH | confusion |
drug | DRUGBANK | MCC |
drug | DRUGBANK | Cysteamine |
drug | DRUGBANK | Gold |
disease | MESH | pneumonia |
disease | MESH | pulmonary tuberculosis |
disease | IDO | host |
disease | IDO | bacteria |
disease | MESH | brain tumors |
disease | MESH | extensively drug resistant tuberculosis |